News from AIDS 2014

The 20th International AIDS Conference (AIDS 2014) is taking place in Melbourne, Australia, 20-25th July 2014.

Our writers will be reporting on key research presented at the conference, publishing news and sending out news summary bulletins by email.

“The coverage made me feel I was at the conference and I appreciate NAM's effort in sharing the bulletins.” NAM bulletin subscriber

aidsmap news from AIDS 2014

Weight gain on ART may raise risk of heart disease and diabetes

People with HIV in the normal weight range who gain a substantial amount of weight shortly after starting antiretroviral therapy (ART) may have an increased risk

Published
25 July 2014
By
Liz Highleyman
Interferon-free hepatitis C treatment works for people on methadone or buprenorphine

People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen

Published
25 July 2014
By
Liz Highleyman
Most gay men who don’t use condoms are mindful of HIV and attempt to reduce their risk

Three-quarters of Australian gay and bisexual men who report unprotected anal intercourse with casual male partners say that they “often” or “always” employ some sort of risk

Published
25 July 2014
By
Roger Pebody
Efavirenz use not linked to neurocognitive impairment

People who use antiretroviral regimens containing efavirenz (Sustiva or Stocrin, also in the Atripla coformulation) were not at higher risk for impaired neurocognitive function, either overall or when looking

Published
25 July 2014
By
Liz Highleyman
How will people use PrEP? iPrEx users talk condoms, pills, anxiety and relief

Interviews with participants in the US sites of the iPrEx study of pre-exposure prophylaxis (PrEP) show that participants who took it mainly used it as an additional

Published
25 July 2014
By
Gus Cairns
The more drugs gay men have taken, the more likely they are to have unprotected sex

The probability of gay men in England having unprotected anal intercourse is strongly associated with the number of recreational drugs they have taken at the time, according

Published
25 July 2014
By
Roger Pebody
Tackling moral judgments about sex and sexuality is vital for HIV prevention

Scientific advances in biomedical prevention and treatment will not reach transgender people, men who have sex with men (MSM) and other populations with the greatest needs

Published
25 July 2014
By
Roger Pebody
ART demand up to 16.8 million by 2016

The projected demand for antiretroviral therapy (ART) will increase to 16.8 million person-years by the end of 2016 in low- and middle-income countries, including 15.7 million person-years of

Published
24 July 2014
By
Lesley Odendal
HIV is increasing in gay men in London because of lack of testing, comparative study finds

A study presented at the 20th International AIDS Conference (AIDS 2014) in Melbourne today compared the HIV epidemics in gay men in San Francisco, US and London,

Published
24 July 2014
By
Gus Cairns
Dolutegravir demonstrates good efficacy despite resistance

Antiretroviral regimens containing the recently approved HIV integrase inhibitor dolutegravir (Tivicay) demonstrated high rates of viral suppression even in treatment-experienced people who had virus with resistance to

Published
24 July 2014
By
Liz Highleyman

Email bulletins

Sign up for conference news bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

NAM’s AIDS 2014 bulletins have been made possible thanks to support from Bristol-Myers Squibb. NAM's wider conference news reporting services have been supported by AbbVie, Gilead Sciences, Janssen and ViiV Healthcare’s Positive Action Programme.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.